基本资料 投资组合 财务数据 基金公告
易方达标普生物科技人民币C(012866) |
净值：
1.7490
|
日增长率：
-0.11%
|
累计净值：1.7490 | 2025-12-25 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| CRSP | CRISPR Therapeutics AG | 20,706.00 | 9,535,267.36 | 2.14 |
| EXEL | 伊克力西斯 | 28,653.00 | 8,408,427.72 | 1.89 |
| ABBV | 艾伯维 | 5,104.00 | 8,397,138.93 | 1.89 |
| MDGL | Madrigal Pharmaceuticals Inc | 2,512.00 | 8,186,629.68 | 1.84 |
| MRNA | Moderna Inc | 44,435.00 | 8,155,380.61 | 1.83 |
| UTHR | 联合治疗 | 2,725.00 | 8,116,948.38 | 1.82 |
| RVMD | Revolution Medicines Inc | 24,133.00 | 8,007,977.37 | 1.80 |
| IONS | Ionis Pharmaceuticals Inc | 16,879.00 | 7,846,064.91 | 1.76 |
| AMGN | 安进 | 3,879.00 | 7,778,062.58 | 1.75 |
| REGN | 再生元制药 | 1,944.00 | 7,766,687.24 | 1.75 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2025-09-30 | 94.77 | - | 6.01 | 444,884,437.23 |
| 2025-06-30 | 94.45 | - | 5.85 | 333,553,426.09 |
| 2025-03-31 | 94.28 | - | 6.80 | 296,810,618.81 |
| 2024-12-31 | 93.19 | - | 7.06 | 305,974,835.24 |
| 2024-09-30 | 94.75 | - | 5.74 | 317,587,742.22 |
微信公众号
证券之星APP
